Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48
- PMID: 12672405
- DOI: 10.1016/s1521-6616(02)00041-4
Prolongation of allogeneic skin graft survival by injection of anti-Ly49A monoclonal antibody YE1/48
Abstract
Ly49A receptors expressed on NK, NKT, and T cells play inhibitory roles in regulating the immune responses in vivo and in vitro. Whether or not injection of anti-Ly49A monoclonal antibody (mAb) YE1/48 can block allograft rejection has not been evaluated. Balb/c mouse recipients received intraperitoneal injections of YE1/48 mAb (0.5 mg) or control mAb or phosphate-buffered saline on days -1 and 10. On day 0, fully MHC-mismatched allogeneic C57BL/6 (B6) skin grafts were implanted. The skin graft survival and anti-donor humoral responses were observed. Whereas allogeneic B6 skin grafts survived 14 days in isotopy control antibody-treated or nontreated Balb/c mice, injection of YE1/48 mAb significantly prolonged B6 skin graft survival to 19 days (P < 0.0005). Injection of YE1/48 mAb into presensitized Balb/c recipients did not significantly delay B6 skin graft rejection. On the other hand, after depleting recipient NK, NKT, and some cytotoxic T cells by injection of anti-asialo GM1, YE1/48 failed to prolong B6 skin graft survival in Balb/c recipients. The present studies indicate that injection of YE1/48 mAb significantly delays allogeneic skin graft rejection in nonsensitized recipients but not in sensitized recipients. The presence of NK, NKT cells, and some cytotoxic T cells may be essential for YE1/48-mediated immunosuppression in vivo.
Similar articles
-
Importance of natural killer cells in the rejection of hamster skin xenografts.Transplantation. 1998 Mar 15;65(5):727-34. doi: 10.1097/00007890-199803150-00021. Transplantation. 1998. PMID: 9521210
-
Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.Transplantation. 1998 Dec 27;66(12):1587-96. doi: 10.1097/00007890-199812270-00004. Transplantation. 1998. PMID: 9884244
-
Inhibition of skin xenograft rejection by depleting T-cell receptor alpha beta-bearing cells without T-cell receptor gamma delta-bearing cells or natural killer cells by monoclonal antibody.Immunology. 1994 Oct;83(2):196-204. Immunology. 1994. PMID: 7835935 Free PMC article.
-
Immune recognition and rejection of allogeneic skin grafts.Immunotherapy. 2011 Jun;3(6):757-70. doi: 10.2217/imt.11.2. Immunotherapy. 2011. PMID: 21668313 Free PMC article. Review.
-
Natural killer cells in lung transplantation.Thorax. 2019 Apr;74(4):397-404. doi: 10.1136/thoraxjnl-2018-212345. Epub 2018 Oct 31. Thorax. 2019. PMID: 30381399 Free PMC article. Review.
Cited by
-
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors.Sci Rep. 2016 Feb 1;6:20250. doi: 10.1038/srep20250. Sci Rep. 2016. PMID: 26833095 Free PMC article.
-
Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin.J Biol Eng. 2017 Dec 13;11:49. doi: 10.1186/s13036-017-0089-9. eCollection 2017. J Biol Eng. 2017. PMID: 29255480 Free PMC article. Review.
-
MOP3, a component of the molecular clock, regulates the development of B cells.Immunology. 2006 Dec;119(4):451-60. doi: 10.1111/j.1365-2567.2006.02456.x. Epub 2006 Aug 22. Immunology. 2006. PMID: 16925591 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials